Vaccine Development
The CDC suggests the HPV vaccine for all guys ages 11 to 12 and those to age 21 who have not had each of the three measurements of the immunization. It is additionally prescribed for gay, swinger, and men who have intercourse with men. Men through age 26 who are immunocompromised, including HIV positive, who have not had every one of the three dosages may likewise profit. The vaccine is best when given to more youthful guys. The vaccine has been demonstrated to forestall genital warts and anal cancers in guys and may counteract diseases of the oropharynx and penis (ACIP, 2014).
- Classes of drugs and mechanism
- Immunology and strategies towards HIV and retroviral infections
- HIV/AIDS and STDs/STIs: Vaccines research and development
- Nucleoside analogues and molecular mechanisms
- HIV: Current pharmaceutical design
Related Conference of Vaccine Development
April 14-15, 2025
12th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
Paris, France
July 24-25, 2025
20th International Conference on Allergic Diseases and Clinical Immunology
Paris, France
August 26-27, 2025
6th International conference on Vaccines, Vaccination and Immunization
Paris, France
Vaccine Development Conference Speakers
Recommended Sessions
- Advanced Techniques involved in STDs
- AIDS stigma and discrimination
- Emerging Technologies towards HIV/AIDS
- Global Epidemiology of HIV/AIDS, STDs, & STIs
- HIV & aging
- HIV in women
- HIV Infection
- HIV Prevention, Treatment & Cure
- HIV Related Infections, Co-Infections and Cancers
- HIV/AIDS, STDs & STIs
- Immunology of HIV/AIDS, STDs & STIs
- knowledge on HIV/AIDS, STDs and STIs
- Lived experience of HIV
- Outbreaks- HIV/AIDS, STDs & STIs
- STD symptoms
- Vaccine Development
- Viral, Bacterial, Fungal & Protozoan STDs
Related Journals
Are you interested in
- Advances in Immunotherapy for Neuroimmune Disorders - Neuroimmunology Congress 2025 (Italy)
- Animal Models & Clinical Trials - Vaccines-Immunization-2025 (France)
- Antibiotic Prophylaxis - Antibiotics 2025 (France)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2025 (France)
- Antibiotic-resistant Bacterial infections - Antibiotics 2025 (France)
- Antibiotics - Antibiotics 2025 (France)
- Antibiotics for Various Diseases and Infections - Antibiotics 2025 (France)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2025 (France)
- Antibodies: Engineering & Therapeutics - Vaccines-Immunization-2025 (France)
- Antimicrobial Peptides - Antibiotics 2025 (France)
- Antimicrobial Therapy - Antibiotics 2025 (France)
- Artificial Intelligence in Neuroimmunology Research - Neuroimmunology Congress 2025 (Italy)
- Autoimmunity in Neurodegenerative Diseases - Neuroimmunology Congress 2025 (Italy)
- Cancer Immunology and Immunotherapy - European Immunology 2025 (France)
- Cancer, Malaria & TB Vaccines - Vaccines-Immunization-2025 (France)
- Cellular and Molecular Immunotherapy in Neuroinfectious Diseases - Neuroimmunology Congress 2025 (Italy)
- Cellular Immunology & Latest Innovations - Vaccines-Immunization-2025 (France)
- Clinical Trials of Antibiotics - Antibiotics 2025 (France)
- Combination & Conjugate Vaccines - Vaccines-Immunization-2025 (France)
- Current Research & Future Challenges - Vaccines-Immunization-2025 (France)
- Current research in antibiotic resistance - Antibiotics 2025 (France)
- Developing Alternatives to Antibiotics - Antibiotics 2025 (France)
- Diagnostic and Technological Novelty of Immunology - European Immunology 2025 (France)
- Different Types of Antibiotics - Antibiotics 2025 (France)
- DNA & Synthetic Vaccines - Vaccines-Immunization-2025 (France)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2025 (France)
- Emerging Viral Neuroinfections - Neuroimmunology Congress 2025 (Italy)
- Epidemiology - European Immunology 2025 (France)
- Fish & Poultry Vaccines - Vaccines-Immunization-2025 (France)
- Gene Editing and Neuroimmune Disorders - Neuroimmunology Congress 2025 (Italy)
- Genomics and Precision Medicine in Neuroimmunology - Neuroimmunology Congress 2025 (Italy)
- Geriatric Immunization - Vaccines-Immunization-2025 (France)
- HIV Vaccines - Vaccines-Immunization-2025 (France)
- Immune System - European Immunology 2025 (France)
- Immunodeficiency - European Immunology 2025 (France)
- Immunogenetics - European Immunology 2025 (France)
- Immunoinformatics & Systems Immunology - European Immunology 2025 (France)
- Immunological Techniques - European Immunology 2025 (France)
- Immunology - European Immunology 2025 (France)
- Immunology & Vaccines - Antibiotics 2025 (France)
- Immunometabolism in Neuroinflammation - Neuroimmunology Congress 2025 (Italy)
- Immunotherapy - European Immunology 2025 (France)
- Immunotoxicology - European Immunology 2025 (France)
- Infectious Diseases - Antibiotics 2025 (France)
- Innate Immunity in Neurological Diseases - Neuroimmunology Congress 2025 (Italy)
- Mechanism and Evolution of Antibiotic Resistance - Antibiotics 2025 (France)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2025 (France)
- Microorganisms Producing Antibiotics - Antibiotics 2025 (France)
- Molecular Pathways in Neuroimmune Disorders - Neuroimmunology Congress 2025 (Italy)
- Neuroimmune Biomarkers: From Discovery to Clinical Application - Neuroimmunology Congress 2025 (Italy)
- Neuroimmune Mechanisms in CNS Infections - Neuroimmunology Congress 2025 (Italy)
- Neuroimmune Responses to Environmental Triggers - Neuroimmunology Congress 2025 (Italy)
- Neuroimmunology - European Immunology 2025 (France)
- Neuroimmunology of Aging and Neurodegeneration - Neuroimmunology Congress 2025 (Italy)
- Neuroimmunology of Pain and Neuropathic Conditions - Neuroimmunology Congress 2025 (Italy)
- Neuroinfectious Disease Epidemiology - Neuroimmunology Congress 2025 (Italy)
- Neuroinflammation and Psychiatric Disorders - Neuroimmunology Congress 2025 (Italy)
- Parasite Immunology - European Immunology 2025 (France)
- Peadiatric Vaccination - Vaccines-Immunization-2025 (France)
- Pediatrics Immunology - European Immunology 2025 (France)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2025 (France)
- Pharmacology & Toxicology - Antibiotics 2025 (France)
- Reproductive Immunology - European Immunology 2025 (France)
- Role of Microglia in Neuroimmunology - Neuroimmunology Congress 2025 (Italy)
- The Blood-Brain Barrier in Health and Disease - Neuroimmunology Congress 2025 (Italy)
- The Microbiome-Neuroimmune Connection - Neuroimmunology Congress 2025 (Italy)
- The Next Generation Approach of Antibiotics - Antibiotics 2025 (France)
- Transplantation Immunology - European Immunology 2025 (France)
- Travel & Edible Vaccines - Vaccines-Immunization-2025 (France)
- Vaccine Production & Development - Vaccines-Immunization-2025 (France)
- Vaccines - Vaccines-Immunization-2025 (France)
- Vaccines & Autism - Vaccines-Immunization-2025 (France)
- Vaccines against Drugs - Vaccines-Immunization-2025 (France)
- Vaccines against Infectious Diseases - Vaccines-Immunization-2025 (France)
- Vaccines for Immune Mediated Diseases - Vaccines-Immunization-2025 (France)
- Vaccines for Pregnant Women & Neonates - Vaccines-Immunization-2025 (France)
- Vaccines for Unconventional Diseases - Vaccines-Immunization-2025 (France)
- Vectors, Adjuvants & Delivery Systems - Vaccines-Immunization-2025 (France)
- Viral Immunology - European Immunology 2025 (France)